Armas Pharmaceuticals Announces Launch of Oncology Generic Erlotinib

MANALAPAN, N.J., Nov. 13, 2019 -- (Healthcare Sales & Marketing Network)-- Armas Pharmaceuticals Inc. (Armas) is announcing the launch of generic Tarceva® (a trademark of Genentech USA, Inc) Tablets. Erlotinib is now available in 25mg, 100mg and 150m...Biopharmaceuticals, Generics, Oncology, Product Launch
Armas Pharmaceuticals, Erlotinib, Tarceva, Genentech, NSCLC